Skip to main content

Table 6 The impacts of UZMDP on healthcare services utilization and expenditures (FE model)

From: Did the universal zero-markup drug policy lower healthcare expenditures? Evidence from Changde, China

 

Inpatient admissions

Total

Drug

Diagnosis

Laboratory

Medical consumables

 

Estimate

Se

Estimate

Se

Estimate

Se

Estimate

Se

Estimate

Se

Estimate

Se

Intercept

-0.309***

0.027

6,801.300***

222.200

3,981.000***

166.000

-2,270.000***

95.980

-461.000***

28.750

-1,731.000***

73.410

UZMDP adoption

0.248***

0.032

669.800*

264.600

-1,338.000***

196.500

3,099.000***

108.900

1,299.000***

32.680

2,055.000***

82.980

R2

0.425 %

0.047 %

0.019 %

0.600 %

0.920 %

0.339 %

 

Outpatient visits

Total

Drug

Diagnosis

Laboratory

Medical consumables

 

Estimate

Se

Estimate

Se

Estimate

Se

Estimate

Se

Estimate

Se

Estimate

Se

Intercept

-0.161**

0.051

-13.210

32.050

430.400***

51.580

-648.817***

13.379

-442.521***

9.784

-639.507***

14.239

UZMDP adoption

0.386***

0.059

153.410***

36.790

-1,516.000***

59.160

348.593***

11.852

189.365***

8.212

372.503***

13.129

R2

0.177 %

0.072 %

0.219 %

1.343 %

1.166 %

1.761 %

  1. aSignificance codes: *** ≤ 0.001, ** ≤ 0.01, * ≤ 0.05
Back to article page

BMC Health Services Research

ISSN: 1472-6963

Contact us